Position in PFE
as of Jun 30, 2026
· filed Aug 21, 2026
Position Value
$286,609,165
+$116,074,552 QoQ
Shares Held
11,902,374
+96.0% QoQ
Ownership
0.209%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#55
of 2,821 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $2,878,468,803 across 10 Drug Manufacturers - General names. PFE ranks #6 (10.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
501,025 | $600,944,465 | |
| 2 | ABBV |
AbbVie Inc.
|
2,097,882 | $527,911,026 | |
| 3 | JNJ |
Johnson & Johnson
|
1,939,364 | $492,540,275 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,702,992 | $347,334,472 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
2,287,888 | $289,051,769 | |
| 6 | PFE |
Pfizer Inc
This page
|
11,902,374 | $286,609,165 | |
| 7 | AZN |
Astrazeneca PLC
|
1,352,177 | $256,399,802 | |
| 8 | AMGN |
Amgen Inc
|
191,247 | $69,254,363 |
All Filings in PFE
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $286,609,165 | 11,902,374 | Shares | Sole | 2026-08-21 | |
| 2026-03-31 | $170,534,613 | 6,073,170 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $51,380,129 | 2,063,459 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $221,398,344 | 8,689,103 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $120,389,705 | 4,966,572 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $254,574,255 | 10,046,340 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $65,404,674 | 2,465,310 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $149,749,885 | 5,174,495 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $133,367,453 | 4,766,528 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $165,711,733 | 5,971,594 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $183,492,834 | 6,373,492 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $138,722,446 | 4,182,166 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $112,761,472 | 3,074,195 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $280,426,519 | 6,873,199 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $163,113,419 | 3,183,322 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $542,674,936 | 12,401,164 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $103,378,957 | 1,971,752 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $238,137,547 | 4,599,914 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $222,349,645 | 3,765,447 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $161,660,482 | 3,758,672 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $128,753,459 | 3,287,882 | Shares | Sole | 2021-07-15 | |
| 2020-12-31 | $34,348,257 | 933,123 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $28,086,849 | 765,310 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $232,726 | 7,117 | Shares | Sole | 2020-07-21 | |
| No filing history on record for this holder in this stock. | ||||||